Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05206682
NA
Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
View on ClinicalTrials.gov
Summary
GnRH-a will be used to postpone period after vaginal repair for Cesarean Section Scar Defect（CSD） patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without GnRH-a, whether delayed period improving the CSD prognosis will be assessed.
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
94
Start Date
2023-05-01
Completion Date
2026-04-30
Last Updated
2024-04-23
Healthy Volunteers
No
Conditions
Interventions
DRUG
Leuprorelin
Leuprorelin will be used to postpone period after vaginal repair.
Locations (1)
Shanghai Jiaotong University xinhua hospital
Shanghai, Shanghai Municipality, China